Machine learning overtakes humans in predicting death or heart attack
Machine learning is overtaking humans in predicting death or heart attack. That's the main message of a study presented today at ICNC 2019.
The International Conference on Nuclear Cardiology and Cardiac CT (ICNC) is co-organised by the American Society of Nuclear Cardiology (ASNC), the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC), and the European Association of Nuclear Medicine (EANM).
By repeatedly analysing 85 variables in 950 patients with known six-year outcomes, an algorithm "learned" how imaging data interacts. It then identified patterns correlating the variables to death and heart attack with more than 90% accuracy.
Machine learning, the modern bedrock of artificial intelligence (AI), is used every day. Google's search engine, face recognition on smartphones, self-driving cars, Netflix and Spotify recommendation systems all use machine learning algorithms to adapt to the individual user.
Study author Dr. Luis Eduardo Juarez-Orozco, of the Turku PET Centre, Finland, said: "These advances are far beyond what has been done in medicine, where we need to be cautious about how we evaluate risk and outcomes. We have the data but we are not using it to its full potential yet."
Doctors use risk scores to make treatment decisions. But these scores are based on just a handful of variables and often have modest accuracy in individual patients. Through repetition and adjustment, machine learning can exploit large amounts of data and identify complex patterns that may not be evident to humans.
Dr. Juarez-Orozco explained: "Humans have a very hard time thinking further than three dimensions (a cube) or four dimensions (a cube through time). The moment we jump into the fifth dimension we're lost. Our study shows that very high dimensional patterns are more useful than single dimensional patterns to predict outcomes in individuals and for that we need machine learning."
The study enrolled 950 patients with chest pain who underwent the centre's usual protocol to look for coronary artery disease. A coronary computed tomography angiography (CCTA) scan yielded 58 pieces of data on presence of coronary plaque, vessel narrowing, and calcification. Those with scans suggestive of disease underwent a positron emission tomography (PET) scan which produced 17 variables on blood flow. Ten clinical variables were obtained from medical records including sex, age, smoking and diabetes.
During an average six-year follow-up there were 24 heart attacks and 49 deaths from any cause. The 85 variables were entered into a machine learning algorithm called LogitBoost, which analysed them over and over again until it found the best structure to predict who had a heart attack or died.
Dr. Juarez-Orozco said: "The algorithm progressively learns from the data and after numerous rounds of analyses, it figures out the high dimensional patterns that should be used to efficiently identify patients who have the event. The result is a score of individual risk."
The predictive performance using the ten clinical variables alone (similar to current clinical practice) was modest, with an area under the curve (AUC) of 0.65 (where 1.0 is a perfect test and 0.5 is a random result). When PET data were added, AUC increased to 0.69. The predictive performance increased significantly (p=0.005) when CCTA data were added to clinical and PET data, giving an AUC 0.82 and more than 90% accuracy.
Dr. Juarez-Orozco said: "Doctors already collect a lot of information about patients—for example those with chest pain. We found that machine learning can integrate these data and accurately predict individual risk. This should allow us to personalise treatment and ultimately lead to better outcomes for patients."